By Benton Bramwell, ND, and Matt Warnock, JD – Where clinical trials of groups seek to average individual variability, N-of-1 trials embrace individual variability. Hogben and Sim argue that careful, successive observations in a single person ought not be viewed as experimentally inferior data because successive observations can, in fact, provide great clarity on the effect of an intervention.
By Donnie Yance – Glucosamine and chondroitin are both recognizes as both effective and safe, especially for managing osteoarthritis and joint pain. However, more research is needed to understand how they might help with other health conditions.
By Alan R. Gaby, MD – Most research demonstrating the clinical benefits of folate has used folic acid, and the small amount of research comparing the efficacy of folic acid and 5-MTHF tends to favor folic acid. There are still questions, but we should be careful about replacing a well-established form of folate with one that has potential problems, and little research supporting its use.
by Jan Ženka, PhD – Immune checkpoint inhibitors have been great, but for some patients, the immune system simply does not see the tumor clearly enough to attack it. What if we could make tumors themselves look more like dangerous invaders?
By Dr. Robert A. Nagourney, MD – By studying cancer metabolism (metabolomics) we can identify signatures that define predisposition to cancer and provide information on the severity of the disease. It turns out that your metabolic signature is what best defines your risk for cancer.Â
By Darrell S.C.S. Misak, ND, RPh – Dr. Reams outlined that women of childbearing years need seven times the calcium of their male counterparts; they lose 7-15 times more calcium than a man for the same pH drift due to hormonal cation exchange. These ratios are clinical observations from thousands of Reams tests and have not been duplicated in controlled academic settings.
By Donnie Yance – Compelling evidence demonstrates that lower ICI doses maintain therapeutic efficacy while improving safety profiles and dramatically reducing costs. Implementation of evidence-based dose optimization represents a critical opportunity to improve global cancer care accessibility while maintaining therapeutic excellence.
By Masoumeh Shayesteh Manesh, ND, MD (IMG) – The gut is central to whole-body repair, and emerging evidence suggests that the gut microbiome influences not only chronic disease and immunity, but also the body’s ability to recover from injury.
By Geo Espinosa, ND, LAc – Current diagnostic tools, such as PSA, mostly predict biopsy positivity or the presence of clinically significant cancer, but do not show the actual risk of dying from prostate cancer, how life expectancy and comorbid disease modify that risk, or whether there is any meaningful benefit to continued screening.
by Holly Christy, ND; Brian Tuckey, PT; Nirnaya Miljacic, PhD; Nayak Polissar, PhD; Meena Vythilingam, MD = Despite the substantial burden to individuals, families, and communities, only a minority of individuals with PTSD receive treatment, and the rates of dropout from treatments are high. We have a need for innovative, rapidly effective treatment options that are well tolerated and accepted by individuals with PTSD.
By Donnie Yance – Kudzu, used traditionally for the treatment of menopausal symptoms. Over the centuries it has been used to treat alcoholism, hangover, gastric distress, high blood pressure and other circulatory problems, colds, flu, diabetes, skin rashes, kidney disease, and diabetic retinopathy, to name a few.
By Geo Espinosa – Melatonin is neither the benign panacea patients assume nor the cardiotoxic agent suggested by headlines. Its value lies in circadian stabilization, vascular support, REM enhancement, and antioxidant function—when used correctly, at the right time, and under clinical guidance.
By Donnie Yance – The future of natural compounds in HER2-positive cancer treatment lies not in their use as monotherapies but in their strategic integration into comprehensive, personalized treatment protocols. The challenge for researchers and clinicians is to move beyond preclinical promise to rigorous clinical validation, establishing evidence-based protocols that harness the therapeutic potential of natural compounds while maintaining the scientific rigor that patients deserve.
by Alan R. Gaby, MD – Smoking cessation, Olive oil, Melatonin, Endometriosis, Heart Failure and Cognitive Decline are some of the topics reviewed in this article.
By Donnie Yance – The convergence of traditional botanical knowledge with modern molecular oncology offers exciting opportunities for drug discovery and development. By combining rigorous scientific investigation with respect for traditional medicine systems, we may unlock the full therapeutic potential of natural mTOR/PI3K inhibitors for the benefit of cancer patients worldwide.
By Geo Espinosa, ND, LAc – Poor sleep isn’t just a nuisance—it’s linked with metabolic syndrome, hypertension, heart disease, cognitive decline, and even higher prostate cancer risk over time. Better sleep isn’t a luxury; it’s a foundation for health, clarity, and quality of life. Strength training can help with that.
By Chris D. Meletis, ND – Nicotinamide adenine dinucleotide (NAD+) is a pivotal coenzyme for cellular metabolism, mitochondrial function, and genomic stability. This article examines the mechanisms, comparative efficacy, clinical and preclinical research, and safety profiles of NR and NMN based on recent peer-reviewed evidence and regulatory findings.​
By Gabrielle Duebendorfer, NMD – There are deeply dysfunctional issues in our medical system, and using inflammatory rhetoric is increasing the political divide, removing any possibility to explore valid issues. We all have our blind spots, yet need to see clearly, and contribute to healthy dialogue, instead of more separation.
It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized.Â
By addressing food sensitivities through targeted testing and personalized dietary interventions, individuals can take a significant step toward reducing inflammation, improving gut health, and enhancing overall well-being.
As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...
"From Practitioner to Leader: Clinical Excellence, Business Mastery & Sustainable Practice" Discover how clinical excellence, business mastery, and sustainable systems can help practitioners grow into confident leaders and build practices designed for long-term impact. Why Attend? Three days of learning, connection, and growth designed for every stage of your practice journey. Learn from Leading Voices Gain insights from top experts in natural health, holistic wellness, and functional medicine. Hands-On Learning Participate in in-depth workshops, real-world case studies, and interactive sessions you can apply immediately. Meaningful Networking Connect with like-minded professionals, students, and exhibitors who share your passion for natural health. Practical Tools & Approaches Explore new strategies and tools to elevate both your practice and your own health journey. Who Should Attend? This conference is built for a wide community of natural health professionals, educators, and advocates - wherever you are in your journey. Licensed & Clinical Practitioners Doctors, chiropractors, acupuncturists, naturopaths, and functional or integrative medicine practitioners looking to sharpen clinical skills and grow into stronger practice leaders. Allied Health Professionals Bio-feedback technicians and other allied practitioners seeking hands-on training and the latest tools in natural and holistic care. Educators & Students Natural health educators and students entering the […]
Join health professionals, farmers, food producers, researchers, educators, nonprofit leaders, chefs, policymakers, community organizers, food advocates, public health practitioners, nutritionists, and other changemakers as we convene to share knowledge, build partnerships, and explore new possibilities for improving health, strengthening communities, and creating more equitable and sustainable food systems. This year’s program features inspiring speakers and practical examples of collaboration at the intersection of food, health, social justice, and planetary well-being. Together, we’ll explore innovative approaches to Food as Medicine, community-led initiatives, nutrition, public health, regenerative agriculture, and equitable access to healthy food. Whether you work in health care, agriculture, food production, education, research, policy, or community development, you will discover new ideas, meaningful connections, and practical strategies to advance healthier, more resilient communities. Virtual | Join from anywhere in the world Check out the Program: https://tinyurl.com/Food-as-Medicine-for-All
Menopause Care in the Longevity Era Longevity medicine is everywhere right now. Supplements, protocols, influencer clinics, patients walking in with questions about interventions their doctors have never heard of. What's missing from most of it is the evidence. The Midlife Women's Health Summit is three days on what the research actually says about menopause care when you add a longevity lens. What works, what doesn't, what's being oversold, and what to tell the patient sitting in front of you. Co-chaired by Lisa Larkin, MD, FACP, MSCP, IF, Jen Gunter, MD, FRCS(C), FACOG, DABPM, ABPMR, and Lauren Streicher, MD, FACOG, MSCP; three of the clearest voices in women's health on separating data from marketing.